Kyushu University Academic Staff Educational and Research Activities Database
List of Papers
Toshihiro Miyamoto Last modified date:2019.07.02

Associate Professor / Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences / Department of Clinical Medicine / Faculty of Medical Sciences


Papers
1. Miyamoto T, Takashima S, Kato K, Takase K, Yoshimoto G, Yoshida S, Henzan H, Osaki K, Kamimura T, Iwasaki H, Eto T, Teshima T, Nagafuji K, Akashi K. , Comparison of cyclosporine and tacrolimus combined with mycophenolate mofetil in prophylaxis for graft-versus-host disease after reduced-intensity umbilical cord blood transplantation., 2017.07, 臍帯血移植における免疫抑制剤の比較.
2. Kuriyama T, Toshihiro Miyamoto, Engulfment of hematopoietic stem cells caused by down-regulation of CD47 is critical in the pathogenesis of hemophagocytic lymphohistiocytosis. , Blood, 2013.01.
3. Toshihiro Miyamoto, Higher incidence of injection site reactions after subcutaneous bortezomib administration on the thigh compared with the abdomen. , Eur J Haematol , 90, 2, 157-161, 2013.02.
4. Toshihiro Miyamoto, Quantitation of hematogones at the time of engraftment is a useful prognostic indicator in allogeneic hematopoietic stem cell transplantation. , Blood , 2013.01.
5. Mori Y, Miyamoto T, Kamezaki K, Kato K, Kikushige Y, Takashima S, Urata S, Shimoda S, Shimono N, Takenaka K, Iwasaki H, Nagafuji K, Teshima T, Akashi K. , Low incidence of adenovirus hemorrhagic cystitis following autologous hematopoietic stem cell transplantation in the rituximab era. , Am J Hematol, 87, 8, 828-30, 2012.08.
6. Kikushige Y, Ishikawa F, Miyamoto T, Shima T, Urata S, Yoshimoto G, Mori Y, Iino T, Yamauchi T, Eto T, Niiro H, Iwasaki H, Takenaka K, Akashi K. , Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia. , Cancer Cell , 2011.02.
7. Oku S, Takenaka K, Kuriyama T, Shide K, Kumano T, Kikushige Y, Urata S, Yamauchi T, Iwamoto C, Shimoda HK, Miyamoto T, Nagafuji K, Kishimoto J, Shimoda K, Akashi K. , JAK2 V617F uses distinct signalling pathways to induce cell proliferation and neutrophil activation. , Br J Haematol , 150, 3, 334-344, 2010.03.
8. Numata A, Miyamoto T, Ohno Y, Kamimura T, Kamezaki K, Tanimoto T, Takase K, Henzan H, Kato K, Takenaka, K, Fukuda T, Harada N, Nagafuji K, Teshima T, Akashi K, Harada M, Eto T. , Long-term outcomes of autologous PBSCT for peripheral T-cell lymphoma: retrospective analysis of the experience of the Fukuoka BMT group. , Bone Marrow Transplant , 45, 2, 311-316, 2010.02.
9. Numata A, Miyamoto T, Ohno Y, Kamimura T, Kamezaki K, Tanimoto T, Takase K, Henzan H, Kato K, Takenaka, K, Fukuda T, Harada N, Nagafuji K, Teshima T, Akashi K, Harada M, Eto T. , Long-term outcomes of autologous PBSCT for peripheral T-cell lymphoma: retrospective analysis of the experience of the Fukuoka BMT group. , Bone Marrow Transplant , 45, 2, 311-316, 2010.02.
10. Abe Y, Ito T, Baba E, Nagafuji K, Kawabe K, Choi I, Arita Y, Miyamoto T, Teshima T, Nakano S, Harada M., Nonmyeloablative allogeneic hematopoietic stem cell transplantation as immunotherapy for pancreatic Cancer, Pancreas , 38, 7, 815-819, 2009.07.
11. Yoshimoto G, Miyamoto T, Tabrizi SJ, Iino T, Rocnik JL, Kikushige Y, Mori Y, Shima T, Iwasaki H, Takenaka K, Nagafuji K, Mizuno SI, Niiro H, Gilliland GD, Akashi K. , FLT3-ITD upregulates MCL-1 to promote survival of stem cells in acute myeloid leukemia via FLT3-ITD-specific STAT5 activation. , Blood , 114, 24, 5034-5043, 2009.05.
12. Kohno K, Nagafuji K, Tsukamoto H, Horiuchi T, Takase K, Aoki K, Henzan H, Kamezaki K, Takenaka K, Miyamoto T, Teshima T, Harada M, Akashi K, Infectious complications in patients receiving autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases. , Transplant Infect Dis , 11, 4, 318-323, 2010.04.
13. Tabrizi SJ, Niiro H, Masui M, Yoshimoto G, Iino T, Kikushige Y, Wakasaki T, Baba E, Shimoda S, Miyamoto T, Hara T, Akashi K. , T cell leukemia/lymphoma 1 and galectin-1 regulate survival/cell death pathways in human naive and IgM+ memory B cells through altering balances in Bcl-2 family proteins, J Immunol , 182(3):1490-9, 2009.03.
14. Takenaka K, Eto T, Nagafuji K, Kamezaki K, Matsuo Y, Yoshimoto G, Harada N, Yoshida M, Henzan H, Takase K, Miyamoto T, Akashi K, Harada M, Teshima T, Oral valganciclovir as preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients, Int J Hematol, 89:231-237, 2009.02.
15. Mori Y, Iwasaki H, Kohno K, Yoshimoto G, Kikushige Y, Okeda A, Uike N, Niiro H, Takenaka K, Nagafuji K, Miyamoto T, Harada M, Takatsu K, Akashi K. , Identification of the human eosinophil lineage-committed progenitor: revision of phenotypic definition of the human common myeloid progenitor, J Exp Med , 206;183-193, 2009.01.
16. Tatsugami K, Eto M, Harano M, Hamaguchi M, Miyamoto T, Morisaki T, Furue M, Akashi K, Naito S, Dendritic cell therapy in combination with interferon-alpha for the treatment of metastatic renal cell carcinoma, Int J Urol , 15(8):694-698, 2008.08.
17. Kikushige Y, Yoshimoto G, Miyamoto T, Iino T, Mori Y, Iwasaki H, Niiro H, Takenaka K, Nagafuji K, Harada M, Ishikawa F, Akashi K.                     , Human flt3 is expressed at the hematopoietic stem cell and the granulocyte/macrophage progenitor stages to maintain cell survival, J Immunol , 180(11):7358-67, 2008.11.
18. Ishikawa F, Yoshida S, Saito Y, Hijikata A, Kitamura H, Tanaka S, Nakamura R, Tanaka T, Tomiyama H, Saito N, Fukata M, Miyamoto T, Lyons B, Ohshima K, Uchida N, Taniguchi S, Ohara O, Akashi K, Harada M, Shultz LD. , Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region, Nat Biotechnol , 25,1315-21, 2007.11.
19. Ishikawa F, Niiro H, Iino T, Yoshida S, Saito N, Onohara S, Miyamoto T, Minagawa H, Fujii SI, Shultz LD, Harada M, Akashi K. , The developmental program of human dendritic cells is operated independently of conventional myeloid and lymphoid pathways. , Blood , 110,3591-6, 2007.10.
20. 55 Matsuo Y, Takeishi S, Miyamoto T, Nonami A, Kikushige Y, Kunisaki Y, Kamezaki K, Tu L, Hisaeda H, Takenaka K, Harad N, Kamimura T, Ohno Y, Eto T, Teshima T, Gondo H, Harada M, Nagafuji K, Toxoplasmosis Encephalitis Following Severe Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation: 17 years Experience in Fukuoka BMT Group, Eur J Haematol , 79(4):317-321, 2007.04.
21. Mori Y, Yoshimoto G, Kumano T, Miyamoto T, Iino T, Takenaka K, Iwasaki H, Harada N, Kinukawa N, Nagafuji K, Teshima T, Shimoda K, Akashi K, Harada M, Distinctive Expression of Myelomonocytic Markers and Down-regulation of CD34 in Acute Myelogenous Leukaemia with FLT3 Tandem Duplication and Nucleophosmin Mutation, Eur J Haematol , 79(1):17-25, 2007.01.
22. Kamezaki K, Kikushige Y, Numata A, Miyamoto T, Takase K, Henzan H, Aoki K, Kato K, Nonami A, Kamimura T, Arima F, Takenaka K, Harada N, Fukuda T, Hayashi S, Ohno Y, Eto T, Harada M, Nagafuji K, Rituximab Does Not Compromise the Mobilization and Engraftment of Autologous Peripheral Blood Stem Cells in Diffuse-Large B-cell Lymphoma, Bone Marrow Transplant , 39(9):523-527, 2007.09.
23. Tsukamoto H, Nagafuji K, Horiuchi T, Miyamoto T, Aoki K, Takase K, Henzan H, Himeji D, Koyama T, Miyake K, Inoue Y, Nakashima H, Otsuka T, Tanaka Y, Nagasawa K, Harada M, A Phase I-II Trial of Autologous Peripheral Blood Stem Cell Transplantation in the Treatment of Refractory Autoimmune Disease, Ann Rheum Dis , 65(4):508-14, 2006.04.
24. Yoshimoto G, Nagafuji K, Miyamoto T, Kinukawa N, Takase K, Eto T, Kato K, Hayashi S, Kamimura T, Ohno Y, Taniguchi S, Harada M, FLT3 mutations in normal karyotype acute myeloid leukemia in first complete remission treated with autologous peripheral blood stem cell transplantation, Bone Marrow Transplant , 10.1038/sj.bmt.1705169, 36, 11, 977-983, 36(11):977-983, 2005.11.
25. Kawano N, Ishikawa F, Shimoda K, Yasukawa M, Nagafuji K, Miyamoto T, Baba E, Tanaka T, Yamasaki S, Gondo H, Otsuka T, Ohshima K, Shultz LD, Akashi K, Harada M, Efficient engraftment of primary adult T-cell leukemia cells in newborn NOD/SCID/beta2-microglobulin(null) mice, Leukemia, 10.1038/sj.leu.2403829, 19, 8, 1384-1390, 19(8):1384-90, 2005.03.
26. Imamura R, Miyamoto T, Yoshimoto G, Kamezaki K, Ishikawa F, Henzan H, Kato K, Takase K, Numata A, Nagafuji K, Okamura T, Sata M, Harada M, Inaba S, Mobilization of human lymphoid progenitors after treatment with granulocyte colony-stimulating factor, J Immunol , 175, 4, 2647-2654, 175:2647-2654, 2005.03.
27. Ishikawa F, Yasukawa M, Lyons B, Yoshida S, Miyamoto T, Yoshimoto G, Watanabe T, Akashi K, Shultz LD, Harada M. , Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chainnull mice, Blood, 10.1182/blood-2005-02-0516, 106, 5, 1565-1573, 106(5):1565-73, 2005.02.
28. Nagafuchi S, Katsuta H, Ohno Y, Inoue Y, Shimoda K, Kogawa K, Ikeda Y, Koyanagi-Katsuta R, Yamasaki S, Tominaga H, Tamiya S, Umemura T, Otsuka T, Miyamoto T, Otsuka T, Harada M, Kudoh J, Shimizu N, Mitogen-activated protein kinase pathway controls autoimmune regulator (AIRE) gene expression in granulo-monocyte colony stimulating factor (GM-CSF)-stimulated myelomonocytic leukemia OTC-4 cells, Immunol Lett , 10.1016/j.imlet.2005.02.008, 99, 1, 130-135, 99(1):130-5, 2005.01.
29. Numata A, Shimoda K, Kamezaki K, Haro T, Kakumitsu H, Shide K, Kato K, Miyamoto T, Yamashita Y, Oshima Y, Nakajima H, Iwama A, Aoki K, Takase K, Gondo H, Mano H, Harada M, Signal transducers and activators of transcription 3 augments the transcriptional activity of CCAAT/enhancer binding protein a in G-CSF signaling pathway, J Biol Chem , 10.1074/jbc.M408442200, 280, 13, 12621-12629, 280(13):12621-9, 2005.02.
30. Gondo H, Himeji D, Kamezaki K, Numata A, Tanimoto T, Takase K, Aoki K, Henzan H, Nagafuji K, Miyamoto T, Ishikawa F, Shimoda K, Inaba S, Tsukamoto H, Horiuchi T, Nakashima H, Otsuka T, Kato K, Kuroiwa M, Higuchi M, Shibuya T, Kamimura T, Kuzushima K, Tsurumi T, Kanda Y, Harada M, Reconstitution of HLA-A*2402-restricted cytomegalovirus-specific T-cells following stem cell transplantation, Int J Hematol , 10.1532/IJH97.04109, 80, 5, 441-448, 80(5):441-8, 2004.04.
31. Nagafuji K, Aoki K, Henzan H, Kato K, Miyamoto T, Eto T, Nagatoshi Y, Ohba T, Obama K, Gondo H, Harada M, Cidofovir for treating adenoviral hemorrhagic cystitis in hematopoietic stem cell transplant recipients, Bone Marrow Transplant , 10.1038/sj.bmt.1704682, 34, 10, 909-914, 34; 909-914, 2004.01.
32. Kamezaki K, Shimoda K, Numata A, Aoki K, Kato K, Takase K, Nakajima H, Ihara K, Haro T, Ishikawa F, Imamura R, Miyamoto T, Nagafuji K, Gondo H, Hara T, Harada M, The lipocalin 24p3, which is an essential molecule in IL-3 withdrawal-induced apoptosis, is not involved in the G-CSF withdrawal-induced apoptosis, Eur J Haematol , 10.1046/j.0902-4441.2003.00160.x, 71, 6, 412-417, 71;412-7, 2003.03.
33. Aoki K, Shimoda K, Oritani K, Matsuda T, Kamezaki K, Muromoto R, Numata A, Tamiya S, Haro T, Ishikawa F, Takase K, Yamamoto T, Yumioka T, Miyamoto T, Nagafuji K, Gondo H, Nagafuchi S, Nakayama KI, Harada M, Limitin, an interferon-like cytokine, transduces inhibitory signals on B-cell growth through activation of Tyk2, but not Stat1, followed by induction and nuclear translocation of Daxx, Exp Hematol , 10.1016/j.exphem.2003.08.01, 31, 12, 1317-1322, 31;1317-22, 2003.03.
34. Kato K, Kamezaki K, Shimoda K, Numata A, Haro T, Aoki K, Ishikawa F, Takase K, Ariyama H, Matsuda T, Miyamoto T, Nagafuji K, Gondo H, Nakayama K, Harada M, Intracellular signal transduction of interferon on the suppression of hematopoietic progenitor cell growth, Brit J Haematol , 10.1046/j.1365-2141.2003.04650.x, 123, 3, 528-535, 123; 528-535, 2003.02.
35. Yamasaki S, Henzan H, Ohno Y, Yamanaka T, Iino T, Itou Y, Kuroiwa M, Maeda M, Kawano N, Kinukawa N, Miyamoto T, Nagafuji K, Shimoda K, Inaba S, Hayashi S, Taniguchi S, Shibuya T, Gondo H, Otsuka T, Harada M, Influence of transplanted dose of CD56+ cells on development of graft-versus-host disease in patients receiving G-CSF-mobilized peripheral blood progenitor cells from HLA-identical sibling donors, Bone Marrow Transplant , 10.1038/sj.bmt.1704165, 32, 5, 505-510, 32; 505-510, 2003.02.
36. Jaiswal S, Traver D, Miyamoto T, Akashi K, Lagasse Eric, Weissman IL, Expression of BCR/ABL and bcl-2 in myeloid progenitors lead to myeloid leukemias, Proc Natl Acad Sci USA , 100;10002-10007, 2003.03.
37. Terskikh AV, Miyamoto T, Chang C, Diatchenko L, Weissman IL, Gene expression analysis of purified hematopoietic stem cells and commited progenitors, Blood, 102; 94-101, 2003.05.
38. Iwasaki-A J, Iwasaki H, Miyamoto T, Watanabe S, Akashi K, Enforced granulocyte/macrophage colony-stimulating factor signals do not support lymphopoiesis, but instruct lymphoid to myelomonocytic lineage conversion, J Exp Med , 10.1084/jem.20021843, 197, 10, 1311-1322, 197; 1311-1322, 2003.01.
39. Na Nakorn T, Miyamoto T, Weissman IL, Characterization of mouse clonogenic megakaryocyte progenitors, Proc Natl Acad Sci USA , 100; 205-210, 2003.01.
40. Shimoda K, Kamesaki K, Numata A, Aoki K, Matsuda T, Oritani K, Tamiya S, Kato K, Takase K, Imamura R, Yamamoto T, Miyamoto T, Nagafuji K, Gondo H, Nagafuchi S, Nakayama K, Harada M, tyk2 is required for the induction and nuclear translocation of Daxx which regulates IFN-alpha-induced suppression of B lymphocyte formation, J Immunol , 169; 4707-11, 2002.02.
41. Miyamoto T, Iwasaki H, Reizis B, Ye M, Graf T, Weissman IL, Akashi K, Myeloid or lymphoid promiscuity as a critical step in hematopoietic lineage commitment, Developmental Cell , 3; 137-147, 2002.02.
42. Manz M, Miyamoto T, Akashi K, Weissman IL, Myeloid or lymphoid promiscuity as a critical step in hematopoietic lineage commitment, Proc Natl Acad Sci USA , 99; 11872-11877, 2002.01.
43. Yuan Y, Zhou L, Miyamoto T, Harakawa N, Hetherington CJ, Burel S, Lagasse E, Weissman IL, Akashi K, Zhang DE, AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations, Proc Natl Acad Sci USA , 98; 10398-10403, 2001.03.
44. Traver D, Miyamoto T, Christensen J, Iwasaki J, Akashi K, Weissman IL, Fetal liver myelopoiesis occurs through distinct, prospectively isolatable progenitor subsets, Blood , 98; 627-635, 2001.01.
45. Manz MG, Traver D, Miyamoto T, Weissman IL, Akashi K, Dendritic cell potentials of early lymphoid and myeloid progenitors, Blood , 97;3333-3341, 2001.03.
46. Mebius R, Miyamoto T, Christensen J, Domen J, Cupedo T, Weissman IL, Akashi K, The fetal liver counterpart of adult commom lymphoid progenitors give rise to all lymphoid lineages, CD45+CD4+CD3- cells, as well as macrophages, J Immunol , 166;6593-6601, 2001.01.
47. Traver D, Akashi K, Manz M, Merad M, Miyamoto T, Engleman EG, Weissman IL, Development of CD8α-positive dendritic cells from a common myeloid progenitor, Science, 290;2152-2154, 2000.04.
48. Takenaka K, Harada M, Fujisaki T, Nagafuji K, Mizuno S, Miyamoto T, Otsuka T, Gondo H, Okamura T, Niho Y, Human thymic epithelial cells maintain long-term survival of clonogenic myeloid and erythroid progenitor cells in vitro, Br J Haematol , 10.1046/j.1365-2141.2000.02337.x, 111, 1, 363-370, 111;363-370, 2000.05.
49. Kondo M, Scherer DC, Miyamoto T, King AG, Akashi K, Sugamura K, Weissman IL, Cell-fate conversion of lymphoid-committed progenitors by instuctive actions of cytokines, Nature , 407;383-386, 2000.04.
50. Miyamoto T, Weissman IL, Akashi K, AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation, Proc Natl Acad Sci USA , 97; 7521-7526, 2000.03.
51. Akashi K, Richie LI, Miyamoto T, Carr WH, Weissman IL, B lymphopoiesis in the thymus, J Immunol , 164; 5221-5226, 2000.02.
52. Akashi K, Traver D, Miyamoto T, Weissman IL, A clonogenic common myeloid progenitor that gives rise to all myeloid lineages, Nature, 404; 193-197, 2000.01.
53. Iwasaki H, Shimoda K, Okamura S, Otsuka T, Nagafuji K, Harada N, Ohno Y, Miyamoto T, Akashi K, Harada M, Niho Y, Production of soluble granulocyte colony-stimulating factor receptors from myelomonocytic cells, J Imuunol , 163, 12, 6907-6911, 163; 6907-6911, 1999.04.
54. Mizuno S-i, Akashi K, Ohshima K, Iwasaki H, Miyamoto T, Uchida N, Shibuya T, Harada M, Kikuchi M, Niho Y, Interferon-γ prevents apoptosis in Epstein-Barr virus-infected natural killer cell leukemia in an autocrine fashion, Blood, 93, 10, 3494-3504, 93; 3494-3504, 1999.02.
55. Katayama Y, Mahmut N, Takimoto H, Maeda Y, Yano T, Kojima K, Azuma T, Hara M, Imajo K, Takahashi S, Kai T, Ohno Y, Miyamoto T, Nagafuji K, Matsue K, Takenaka K, Teshima T, Shinagawa K, Ishimaru F, Omoto E, Harada M, Hematopoietic progenitor cells from allogeneic bone marrow transplant donors circulate in the very early posttransplant period, Bone Marrow Transplant , 23; 659-665, 1999.02.
56. Tokunaga Y, Miyamoto T, Okamura T, Eto T, Gondo H, Kamimura T, Okamura S, Niho Y, Effect of thrombopoietin on proliferation of blasts from CD7-positive acute myelogenous leukaemia, Br J Haematol , 10.1046/j.1365-2141.1998.00915.x, 102, 5, 1232-1240, 102;1232-1240, 1998.01.
57. Gondo H, Harada M, Miyamoto T, Takenaka K, Tanimoto K, Mizuno S, Fujisaki T, Nagafuji K, Hayashi S, Eto T, Taniguchi S, Akashi K, Harada M, Yamasaki K, Shibuya T, Matsuishi E, Ohno Y, Makino S, Takamatsu Y, Muarakawa M, Teshima T, Hirota Y, Okamura T, Kinukawa N, Inaba S, Niho Y, Autologous peripheral blood stem cell transplantation for acute myelogenous leukemia, Bone Marrow Transplant , 10.1038/sj.bmt.1700979, 20, 10, 821-826, 20;821-826, 1997.04.
58. Teshima T, Sunami K, Bessho A, Shinagawa K, Omoto E, Ueoka H, Harada M, Ohno Y, Miyoshi T, Miyamoto T, Higuchi M, Circulating immature cell counts on the harvest day predict the yields of CD34+ cells collected after granulocyte colony-stimulating factor plus chemotherapy-induced mobilization of peripheral blood stem cell, Blood, 89, 12, 4660-4661, 89;4660-4661, 1997.03.
59. Takenaka K, Gondo H, Tanimoto K, Nagafuji K, Fujisaki T, Mizuno S, Miyamoto T, Okamura T, Hayashi S, Eto T, Osaki K, Yamasaki K, Shibuya T, Harada N,Teshima T, Matsuishi E, Minematsu T, Minamishima Y, Harada M, Niho Y, Fukuoka Bone Marrow Transplantation Group, Increased incidence of cytomegalovirus (CMV) infection and CMV-associated disease after allogeneic bone marrow transplantation from unrelated donors, Bone Marrow Transplant , 10.1038/sj.bmt.1700637, 19, 3, 241-248, 19;241-248, 1997.03.
60. Miyamoto T, Inaba S, Harada M, Makino S, Teshima T, Takamatsu Y, Eto T, Nagafuji K, Mizuno S, Gondo H, Niho Y, Collection and transplantation of autologous peripheral blood stem cells in adults, Jpn J Apheresis , 16; 50-55, 1997.04.
61. Katayama Y, Yano T, Bessho A, Deguchi S, Sunami K, Mahmut N, Shinagawa K, Omoto E, Makino S, Miyamoto T, Mizuno S, Fukuda T, Eto T, Fujisaki T, Ohno Y, Inaba S, Niho Y, Harada M, The effects of a simplified method for cryopreservation and thawing procedures on peripheral blood stem cells., Bone Marrow Transplant , 10.1038/sj.bmt.1700644, 19, 3, 283-287, 19; 283-287, 1997.01.
62. Harada M, Teshima T, Fujisaki T, Mizuno S, Miyamoto T, Takamatsu Y, Kubota A, Ohno Y, Kuroiwa M, Takenaka K, Eto T, Akashi K, Gondo H, Okamura T, Inaba S, Niho Y, Granulocyte colony-stimulating factor induced mobilization of peripheral blood stem cells for autologous and allogeneic Transplantation, Cancer Chemother Pharmacol , 10.1007/s002800051051, 38, S115-S119, 38; 115-119, 1996.03.
63. Takenaka K, Mizuno S, Harada M, Nagafuji K, Miyamoto T, Iwasaki H, Fujisaki T, Kubota A, Ohno Y, Arima F, Shigematsu H, Gondo H, Okamura T, Okamura S, Inaba S, Niho Y, Generation of human natural killer cells from peripheral blood CD34+ cells mobilized by granulocyte colony-stimulating factor, Br J Haematol , 10.1046/j.1365-2141.1996.408950.x, 92, 4, 788-794, 1996.03.
64. Miyamoto T, Nagafuji K, Akashi K, Harada M, Kyo T, Akashi T,, Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia, Blood, 87, 11, 4789-4796, 87;4789-4796, 1996.01.
65. Harada M, Nagafuji K, Fujisaki T, Kubota A, Mizuno S, Takenaka K, Miyamoto T, Ohno Y, Gondo H, Kuroiwa M, Okamura T, Inaba S, Niho Y, G-CSF-induced mobilization of peripheral blood stem cells from healthy adults for allogeneic transplantation, J Hematotherapy , 5; 63-71, 1996.01.
66. Miyamoto T, Akashi K, Hayashi S, Gondo H, Murakawa M, Tanimoto K, Harada M, Niho Y, Serum concentration of soluble interleukin-2 receptor for monitoring acute graft-versus-host disease, Bone Marrow Transplant, 17, 2, 185-190, 17:185-190, 1996.01.
67. Miyamoto T, Nagafuji K, Harada M, Yamasaki K, Shibuya T, Okamura T, Niho Y, Characterization of blasts from a patient with eosinophilic blast crisis of chronic myelogenous leukemia, Br J Haematol, 89, 1, 207-210, 89; 207-210, 1995.01.
68. Miyamoto T, Nagafuji K, Harada M, Eto T, Fujisaki T, Kubota A, Akashi K, Mizuno S, Takenaka K, Kanaji T, Gondo H, Okamura T, Inaba S, Niho Y, Quantitative analysis of AML1/ETO transcripts in peripheral blood stem cell harvests from patients with t(8;21) acute myelogenous leukemia, Br J Hematol, 10.1111/j.1365-2141.1995.tb05258.x, 91, 1, 132-138, 91;132-138, 1995.01.
69. Nagafuji K, Shibuya T, Harada M,Mizuno S, Takenaka K, Miyamoto T, Okamura T, Gondo H, Niho Y, Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells, Blood, 86, 3, 883-889, 86; 883-889, 1995.01.
70. Matue K, Miyamoto T, Ito M, Tsukuda K, Late appearance of the Philadelphia chromosome with monosomy 7 in a patient with de novo AML with trilineage myelodysplasia, Am J Hematol, 10.1002/ajh.2830490413, 49, 4, 341-346, 49; 341-346, 1995.01.
71. Akashi K, Hayashi S, Gondo H, Mizuno S,Harada M, Tamura K,, Involvement of interferon-g and macrophage colony-stimulating factor in pathogenesis of haemophagocytic lymphohistiocytosis in adults, Br J Haematol, 10.1111/j.1365-2141.1994.tb04905.x, 87, 2, 243-250, 87; 243-250, 1994.01.